A. Taketoshi et al.
Bull. Chem. Soc. Jpn. Vol. 80, No. 12 (2007) 2421
were done on silica-gel 60 F254-coated plates (E. Merck AG,
Germany). Column chromatography was carried out with
Wakogel C-200 gel and the indicated eluent. Preparative thin-
layer chromatography was performed on silica-gel-coated plates
(Wakogel B-5F, 20 cm ꢃ 20 cm). Diethyl ether (Et2O) (Dehydrat-
ed) and tetrahydrofuran (THF) (Dehydrated, stabilizer free), pur-
chased from Kanto Chemical Co., Inc., were used in anhydrous
reactions. Other solvents were purified according to standard
procedures.
Addition Reaction of Allyltrimethylsilane to 3,4-Dihydro-
4-phenylisoquinoline (1) in the Presence of Isobutyl Chloro-
formate and Trimethylsilyl Triflate (Table 1, Entry 4). Under
an argon atmosphere, to a solution of 3,4-dihydro-4-phenyliso-
quinoline (1)11 (60.9 mg, 0.29 mmol) in CH2Cl2 (3 mL) was added
isobutyl chloroformate (57 mL, 0.44 mmol) at room temperature.
After stirring for 30 min, allyltrimethylsilane (94 mL, 0.59 mmol)
and trimethylsilyl triflate (11 mL, 0.06 mmol) were added to the
reaction mixture. Then, the reaction mixture was stirred for 1 h.
CH2Cl2 and saturated aqueous NaHCO3 were added to the reac-
tion mixture, and the organic layer was separated. The aqueous
layer was extracted with CH2Cl2. The combined organic layers
were washed successively with water and brine and dried over an-
hydrous Na2SO4. The solvent was removed under reduced pres-
sure, and the residue was separated by preparative thin-layer chro-
matography (silica-gel, hexane/Et2O = 10/1 ꢃ3) to give trans-
2a (67.9 mg, 64%) and cis-2a (24.7 mg, 23%).
Isobutyl trans-1-Allyl-4-phenyl-1,2,3,4-tetrahydroisoquino-
line-2-carboxylate (trans-2a): Colorless solid. mp: 65.4–65.6 ꢂC
(from hexane); IR (KBr, cmꢁ1): 3025, 2960, 1694, 1427, 1219,
1127, 914, 752, 699; 1H NMR (CDCl3): ꢀ 0.58–0.91 (6H, m),
1.40–1.54 and 1.83–1.92 (1H, m), 2.64 (2H, t, J ¼ 7:9 Hz), 3.38
(1H, dd, J ¼ 6:6, 10.2 Hz), 3.55–3.81 (2H, m), 4.11–4.31 (2H, m),
5.01–5.09 (2H, m), 5.28–5.33 and 5.47–5.52 (1H, m), 5.82–5.98
(1H, m), 6.95 (3H, t, J ¼ 9:7 Hz), 7.10–7.25 (6H, m); 13C NMR
(CDCl3): ꢀ 18.9, 19.0, 19.1, 27.7, 28.0, 41.1, 41.5, 44.5, 44.7,
53.6, 71.2, 71.4, 117.2, 117.5, 126.2, 126.5, 126.7, 128.1, 128.1,
129.9, 134.4, 134.7, 135.9, 136.9, 143.9, 155.7; Found: C, 78.99;
H, 7.78; N, 3.82%. Calcd for C23H27NO2: C, 79.05; H, 7.79; N,
4.01%.
53.8, 66.8, 67.0, 117.4, 126.4, 126.6, 126.8, 126.8, 127.4, 127.5,
127.8, 128.0, 128.2, 130.0, 134.6, 135.8, 136.3, 136.8, 143.9,
155.5; Found: C, 81.37; H, 6.67; N, 3.51%. Calcd for C26H25NO2:
C, 81.43; H, 6.57; N, 3.65%.
Benzyl cis-1-Allyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline-
2-carboxylate (cis-2b): Colorless oil. IR (neat, cmꢁ1): 3028,
1
2935, 1699, 1428, 1220, 1125, 914, 736, 700; H NMR (CDCl3):
ꢀ 2.69 (2H, dd, J ¼ 8:1, 17.3 Hz), 3.17–3.34 (1H, m), 4.09–4.21
(1H, m), 4.35 (dd, J ¼ 5:9, 13.7 Hz) and 4.49 (dd, J ¼ 5:9, 13.7
Hz) (1H), 5.00–5.25 (4H, m), 5.31 (t, J ¼ 6:9 Hz) and 5.45 (t,
J ¼ 6:9 Hz) (1H), 5.76–5.99 (1H, m), 6.80 (1H, t, J ¼ 9:1 Hz),
7.05 (1H, t, J ¼ 5:8 Hz), 7.11–7.35 (12H, m); 13C NMR (CDCl3):
ꢀ 41.2, 41.4, 44.5, 44.8, 45.0, 45.3, 54.2, 54.5, 67.0, 67.3, 117.3,
117.6, 126.1, 126.2, 126.4, 126.5, 126.6, 126.7, 126.8, 126.9,
127.5, 127.8, 127.9, 128.0, 128.3, 128.5, 128.9, 129.0, 129.4,
129.6, 134.4, 134.5, 136.9, 137.1, 137.3, 137.6, 142.1, 154.9,
155.0; Found: C, 81.32; H, 6.57; N, 3.44%. Calcd for C26H25NO2:
C, 81.43; H, 6.57; N, 3.65%.
Ethyl trans-1-Allyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline-
2-carboxylate (trans-2c): Colorless oil. IR (neat, cmꢁ1): 3024,
1
2979, 1693, 1427, 1220, 1127, 914, 752, 699; H NMR (CDCl3):
ꢀ 0.75 (t, J ¼ 6:9 Hz) and 1.19 (br) (3H), 2.63 (2H, t, J ¼ 7:6 Hz),
3.60 (1H, dd, J ¼ 3:3, 12.9 Hz), 3.70 (2H, q, J ¼ 7:8 Hz), 4.04–
4.31 (2H, m), 5.02–5.09 (2H, m), 5.31–5.51 (1H, m), 5.81–5.97
(1H, m), 6.91–7.00 (3H, m), 7.11–7.25 (6H, m); 13C NMR
(CDCl3): ꢀ 14.1, 41.1, 44.6, 44.7, 53.4, 53.7, 60.9, 117.2, 126.2,
126.6, 126.8, 128.0, 128.1, 128.2, 129.9, 134.8, 135.8, 137.1,
143.9, 155.7; Found: C, 78.49; H, 7.33; N, 4.25%. Calcd for
C21H23NO2: C, 78.47; H, 7.21; N, 4.36%.
Ethyl cis-1-Allyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline-2-
carboxylate (cis-2c): Colorless solid. mp 81.6–82.4 ꢂC (from
hexane); IR (KBr, cmꢁ1): 3027, 2980, 1696, 1441, 1222, 1129,
916, 759, 709; 1H NMR (CDCl3): ꢀ 1.24–1.31 (3H, m), 2.70 (2H,
dd, J ¼ 6:8, 11.1 Hz), 3.14–3.31 (1H, m), 4.07–4.23 (3H, m), 4.29
(dd, J ¼ 5:9, 13.5 Hz) and 4.47 (dd, J ¼ 5:9, 13.5 Hz) (1H), 5.05–
5.13 (2H, m), 5.29 (t, J ¼ 6:9 Hz) and 5.43 (t, J ¼ 6:9 Hz) (1H),
5.82–6.00 (1H, m), 6.81 (1H, t, J ¼ 8:4 Hz), 7.04–7.09 (1H, m),
7.11–7.36 (7H, m); 13C NMR (CDCl3): ꢀ 14.7, 41.2, 41.4, 44.2,
44.8, 44.9, 45.2, 54.0, 54.3, 61.3, 117.2, 117.4, 126.0, 126.4,
126.5, 126.7, 126.8, 126.8, 128.5, 128.9, 129.0, 129.3, 129.6,
134.4, 134.6, 137.1, 137.2, 137.3, 137.7, 142.2, 155.2; Found: C,
78.35; H, 7.22; N, 4.13%. Calcd for C21H23NO2: C, 78.47; H,
7.21; N, 4.36%.
Addition Reaction of Allylmagnesium Bromide to 3,4-Di-
hydro-4-phenylisoquinoline (1) (Table 2, Entry 1). Under an
argon atmosphere, to magnesium turnings (214 mg, 8.8 mmol) in
THF (2 mL) was added a small amount of 1,2-dibromoethane as
initiator at room temperature. Then, freshly distilled allyl bromide
(484 mg, 4.0 mmol) in THF (2 mL) was added to a reaction mix-
ture over 40 min at ꢁ5 ꢂC. After 1 h, the clear supernatant solution
of allylmagnesium bromide (0.93 mL, 0.93 mmol) was added
slowly (10 min) to the stirred solution of 3,4-dihydro-4-phenyliso-
quinoline (1) (77.4 mg, 0.37 mmol) in THF (4 mL) using a syringe
at ꢁ78 ꢂC under an argon atmosphere. After stirring for 1 h, satu-
rated aqueous NH4Cl and ethyl acetate were added to the reaction
mixture. The organic layer was separated, and the aqueous layer
was extracted with ethyl acetate. The combined organic layers
were washed successively with water and brine and dried over an-
hydrous Na2SO4. The solvent was removed under reduced pres-
sure, and the residue was separated by preparative thin-layer chro-
matography (silica-gel, hexane/Et2O = 1/1 ꢃ3) to give cis-3
(35.2 mg, 38%) and trans-3 (44.3 mg, 48%).
Isobutyl
line-2-carboxylate (cis-2a):
cis-1-Allyl-4-phenyl-1,2,3,4-tetrahydroisoquino-
Colorless oil. IR (neat, cmꢁ1):
3027, 2960, 1699, 1427, 1219, 1126, 915, 758, 704; 1H NMR
(CDCl3): ꢀ 0.95 (6H, dd, J ¼ 4:0, 6.6 Hz), 1.96 (1H, m), 2.71 (2H,
t, J ¼ 8:1 Hz), 3.15–3.33 (1H, m), 3.82–3.99 (2H, m), 4.11–4.23
(1H, m), 4.30 (dd, J ¼ 5:9, 13.9 Hz) and 4.47 (dd, J ¼ 6:3, 13.5
Hz) (1H), 5.06–5.13 (m, 2H), 5.28 (t, J ¼ 7:0 Hz) and 5.43 (t,
J ¼ 7:0 Hz) (1H), 5.85–6.00 (1H, m), 6.81 (1H, t, J ¼ 8:4 Hz),
7.05–7.35 (8H, m); 13C NMR (CDCl3): ꢀ 19.2, 19.3, 28.1, 41.2,
41.4, 44.4, 44.8, 45.1, 45.4, 54.1, 54.6, 71.5, 71.7, 117.2, 117.5,
126.1, 126.1, 126.4, 126.6, 126.7, 126.8, 126.9, 127.0, 128.5,
128.6, 128.9, 129.0, 129.4, 129.6, 134.5, 134.6, 137.1, 137.3,
137.8, 142.3, 155.4; Found: C, 78.78; H, 7.83; N, 3.79%. Calcd
for C23H27NO2: C, 79.05; H, 7.79; N, 4.01%.
In a manner similar to 2a, trans- and cis-2b, 2c were obtained.
Benzyl trans-1-Allyl-4-phenyl-1,2,3,4-tetrahydroisoquino-
line-2-carboxylate (trans-2b): Colorless oil. IR (neat, cmꢁ1):
3028, 2935, 1694, 1426, 1219, 1126, 915, 753, 731; 1H NMR
(CDCl3): ꢀ 2.62–2.74 (2H, m), 3.64 (1H, dd, J ¼ 4:0, 13.5 Hz),
4.11–4.35 (2H, m), 4.62 (1H, d, J ¼ 12:5 Hz), 4.83 (1H, d, J ¼
12:5 Hz), 4.86–5.25 (2H, m), 5.31–5.36 and 5.50–5.55 (1H, m),
5.72–5.98 (1H, m), 6.84 (1H, d, J ¼ 3:6 Hz), 6.93–7.00 (3H, m),
7.11–7.49 (10H, m); 13C NMR (CDCl3): ꢀ 41.1, 44.4, 44.7,